Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization

Eur J Heart Fail. 2018 May;20(5):938-940. doi: 10.1002/ejhf.949. Epub 2017 Sep 26.

Josep Lupón^{1

2

3}, Joanne Simpson⁴, John J V McMurray⁴, Marta de Antonio^{1

2}, Joan Vila^{5

6}, Isaac Subirana^{5

6}, Jaume Barallat⁷, Pedro Moliner¹, Mar Domingo¹, Elisabet Zamora^{1

2

3}, Antoni Bayes-Genis^{1

2

3}

¹ Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
² Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
³ CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.
⁴ Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
⁵ IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
⁶ CIBER Epidemiology and Public Health, Barcelona, Spain.
⁷ Biochemistry Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

No abstract available

Publication types